Reproductive Medicine Associates of New York (RMA of NY), located at 635 Madison Ave in Midtown Manhattan, is one of New York City's most prominent and research-active fertility practices. The 635 Madison Ave address — in the heart of Midtown's commercial corridor, steps from Central Park and accessible from virtually every corner of the city — reflects the practice's positioning as a premier fertility destination for metropolitan New York patients. RMA of NY is distinct from Reproductive Medicine Associates of New Jersey (RMA of NJ), though both are affiliated with the broader RMA network. New York's fertility insurance mandate fully applies at this location. New York patients can also browse the New York fertility clinic directory.
Physicians and Clinical Team
RMA of NY's physician team has established a national and international reputation for clinical excellence and research productivity. The practice's physicians have published extensively in the peer-reviewed literature on IVF laboratory optimization, PGT, sperm-related infertility, and reproductive outcomes. Board-certified in reproductive endocrinology and infertility by ABOG, the physicians at RMA of NY have completed fellowship training at elite programs and continue to contribute to the specialty through research, teaching, and professional leadership.
The clinic's multidisciplinary team includes fellowship-trained REIs, dedicated IVF nurses, andrologists, embryologists with deep experience in advanced laboratory techniques, genetic counselors, a urology team experienced in male-factor workup and surgical sperm retrieval, and patient care coordinators. RMA of NY's patient communication systems are designed to provide responsive support through the intensive monitoring phase of treatment — a particularly important quality given the complexity and emotional weight of IVF in a New York City context.
Services and Treatments
RMA of NY offers a comprehensive and advanced reproductive medicine program from its Midtown Manhattan location, including:
- Comprehensive fertility consultation and diagnostic evaluation
- AMH, antral follicle count, and complete ovarian reserve workup
- Advanced semen analysis and male-factor evaluation
- Surgical sperm retrieval (TESE, MESA, PESA) for azoospermia
- Ovulation induction and monitored cycles
- Intrauterine insemination (IUI)
- In vitro fertilization (IVF) — learn more at our IVF guide
- Intracytoplasmic sperm injection (ICSI)
- Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR)
- Comprehensive chromosome screening
- Frozen embryo transfer (FET)
- Egg freezing and embryo banking
- Donor egg cycles (fresh and frozen)
- Donor sperm coordination
- Gestational carrier coordination
- Third-party reproduction legal and medical support
- Recurrent pregnancy loss evaluation
- Oncofertility consultation
- Fertility preservation for gender-affirming care
Laboratory and Success Rates
RMA of NY's laboratory program is among the most investigated in reproductive medicine. The practice has contributed to foundational research on comprehensive chromosome screening, vitrification, and the genetic determinants of IVF outcomes. The laboratory operates under certified directors and applies state-of-the-art equipment and protocols — including time-lapse embryo imaging, optimized culture media, and rigorous vitrification procedures. RMA of NY's commitment to single embryo transfer is grounded in the laboratory's confidence in embryo selection accuracy, which is central to achieving strong success rates while minimizing multiple pregnancies.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
The 635 Madison Ave address in Midtown Manhattan is one of the most accessible medical office locations in the United States. Within walking distance of Grand Central Terminal, accessible from every major subway line, and served by the Lexington, Fifth Avenue, and Park Avenue bus corridors, the clinic is reachable from anywhere in New York City, Long Island, New Jersey, Connecticut, and Westchester with relative ease. For patients who travel for care from elsewhere in the country, JFK, LaGuardia, and Newark airports are all accessible via public transit.
Midtown Manhattan's patient population is exceptionally diverse — in profession, nationality, family structure, and cultural background. RMA of NY serves patients across this full spectrum, including single women and men pursuing solo parenthood, LGBTQ+ couples with complex third-party needs, patients with cancer diagnoses seeking urgent fertility preservation, and high-achieving professionals navigating infertility alongside demanding careers. The practice's urban sophistication and depth of subspecialty resources align with the expectations of this patient community.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
New York State has a comprehensive infertility insurance mandate. State-regulated health insurance plans that cover pregnancy-related services must cover the diagnosis and treatment of infertility, including IVF, IUI, and embryo cryopreservation, when medically necessary. The mandate provides up to three completed oocyte retrievals per lifetime for qualifying patients and applies to both individual and employer-sponsored plans regulated by New York State.
For Manhattan patients — many of whom work for large financial, legal, media, or technology firms — the insurance landscape is complex. Large employers that self-insure under federal ERISA law are not bound by New York's mandate, and coverage varies enormously by employer. Many major New York City employers have voluntarily added fertility benefits in recent years, but some have not. RMA of NY's financial team is highly experienced in navigating this complexity, including appeals, prior authorization, and identifying all available coverage sources. For patients without coverage, multi-cycle packages, Compassionate IVF programs, and third-party financing are all available. Medication costs may be partially offset by pharmaceutical assistance programs for qualifying patients.
Frequently Asked Questions
How is RMA of NY different from RMA of NJ? RMA of NY (Reproductive Medicine Associates of New York) and RMA of NJ (Reproductive Medicine Associates of New Jersey) are affiliated but distinct practices within the broader RMA network. They share research ties and a commitment to evidence-based care but operate independently, with separate physician teams, laboratories, and administrative structures. Patients should confirm which entity they are engaging with when scheduling.
What is the RMA network, and what does network affiliation mean for patients? The RMA network is a group of affiliated fertility practices that share research programs, scientific resources, and quality standards. Network affiliation provides access to collaborative research protocols, centralized genetics expertise, and shared scientific advances. For patients, this can mean access to cutting-edge protocols and investigational treatments that smaller independent practices cannot offer.
Does the clinic offer services for transgender and non-binary patients? Yes. RMA of NY serves transgender and non-binary patients seeking fertility preservation before or during gender-affirming medical or surgical care, as well as those seeking to build families through ART. The practice has the clinical expertise to navigate the complex fertility considerations that arise with gender-affirming hormone therapy and can coordinate with gender medicine specialists.
Is same-day diagnosis and treatment planning available? RMA of NY can often compress the initial diagnostic timeline significantly, sometimes completing baseline testing — ovarian reserve panel, ultrasound, semen analysis — within a short window of the first consultation. For patients with time-sensitive situations (cancer diagnosis, significant age-related concerns), expedited evaluation can often be arranged. Patients in urgent situations should communicate this need when scheduling.